NCT07534215 The Effect of EEG and BIS-guided Anaesthesia on the Incidence of Emergent Delirium in Children
| NCT ID | NCT07534215 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Ostrava |
| Condition | Emergence Delirium, Anesthesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 540 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 540 participants in total. It began in 2026-01-01 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to compare two modalities of measuring the depth of general anaesthesia on the incidence of emergent delirium in children.
Eligibility Criteria
Inclusion Criteria: * Patient aged 1-6 years indicated for surgery (hernioplasty, orchidopexy) * Consent of parents/legal guardians * Health status corresponding to ASA (American Society of Anesthesiologists) I and II Exclusion Criteria: * Disagreement of parents/legal guardians with inclusion in the study * Neurological disease, severe hearing and vision impairment * Health status corresponding to ASA (American Society of Anesthesiologists) III and above
Contact & Investigator
Vilém Novák, MD, Ph.D.
PRINCIPAL INVESTIGATOR
University Hospital Ostrava
Frequently Asked Questions
Who can join the NCT07534215 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 6 Years, studying Emergence Delirium, Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07534215 currently recruiting?
Yes, NCT07534215 is actively recruiting participants. Contact the research team at jiri.hyncica@fno.cz for enrollment information.
Where is the NCT07534215 trial being conducted?
This trial is being conducted at Ostrava, Czechia.
Who is sponsoring the NCT07534215 clinical trial?
NCT07534215 is sponsored by University Hospital Ostrava. The principal investigator is Vilém Novák, MD, Ph.D. at University Hospital Ostrava. The trial plans to enroll 540 participants.